Search

Hai V Tran

Examiner (ID: 9064, Phone: (571)270-7650 , Office: P/2845 )

Most Active Art Unit
2845
Art Unit(s)
2611, 2845, 2426, 4100, 2711, 2623, 2423, 2491, 2821
Total Applications
1291
Issued Applications
923
Pending Applications
111
Abandoned Applications
257

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17776556 [patent_doc_number] => 20220242905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => MODIFIED PEPTIDES AND THEIR USE [patent_app_type] => utility [patent_app_number] => 17/278558 [patent_app_country] => US [patent_app_date] => 2019-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12655 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278558 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/278558
MODIFIED PEPTIDES AND THEIR USE Sep 25, 2019 Abandoned
Array ( [id] => 17578783 [patent_doc_number] => 20220135638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/279266 [patent_app_country] => US [patent_app_date] => 2019-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279266 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/279266
GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF Sep 23, 2019 Pending
Array ( [id] => 15342647 [patent_doc_number] => 20200009215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS [patent_app_type] => utility [patent_app_number] => 16/577880 [patent_app_country] => US [patent_app_date] => 2019-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23908 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16577880 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/577880
AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS Sep 19, 2019 Abandoned
Array ( [id] => 15454429 [patent_doc_number] => 20200040039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND [patent_app_type] => utility [patent_app_number] => 16/577517 [patent_app_country] => US [patent_app_date] => 2019-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47815 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16577517 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/577517
Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound Sep 19, 2019 Issued
Array ( [id] => 18101251 [patent_doc_number] => 11541122 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-03 [patent_title] => Glucose sensitive insulins and uses thereof [patent_app_type] => utility [patent_app_number] => 17/274802 [patent_app_country] => US [patent_app_date] => 2019-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18163 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274802 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/274802
Glucose sensitive insulins and uses thereof Sep 17, 2019 Issued
Array ( [id] => 15324137 [patent_doc_number] => 20200002398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => De Novo Design of Potent and Selective Interleukin Mimetics [patent_app_type] => utility [patent_app_number] => 16/572038 [patent_app_country] => US [patent_app_date] => 2019-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32010 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16572038 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/572038
De novo design of potent and selective interleukin mimetics Sep 15, 2019 Issued
Array ( [id] => 15342677 [patent_doc_number] => 20200009230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => COMPOSITION AND METHODS FOR TREATING ISCHEMIC WOUNDS AND INFLAMMATORY CONDITIONS [patent_app_type] => utility [patent_app_number] => 16/571383 [patent_app_country] => US [patent_app_date] => 2019-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16571383 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/571383
Composition and methods for treating ischemic wounds and inflammatory conditions Sep 15, 2019 Issued
Array ( [id] => 15553497 [patent_doc_number] => 20200061160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-27 [patent_title] => USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK [patent_app_type] => utility [patent_app_number] => 16/566499 [patent_app_country] => US [patent_app_date] => 2019-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22548 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16566499 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/566499
USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK Sep 9, 2019 Abandoned
Array ( [id] => 15454427 [patent_doc_number] => 20200040038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => Process of Preparing Guanylate Cyclase C Agonists [patent_app_type] => utility [patent_app_number] => 16/546707 [patent_app_country] => US [patent_app_date] => 2019-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28855 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16546707 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/546707
Process of Preparing Guanylate Cyclase C Agonists Aug 20, 2019 Abandoned
Array ( [id] => 17035151 [patent_doc_number] => 20210252109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => USE OF GHRP-6 AS LATE CARDIOPROTECTIVE AND CARDIAC RESTORATION MEDICAMENT [patent_app_type] => utility [patent_app_number] => 17/269874 [patent_app_country] => US [patent_app_date] => 2019-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6970 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269874 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/269874
Use of GHRP-6 as late cardioprotective and cardiac restoration medicament Aug 18, 2019 Issued
Array ( [id] => 16086677 [patent_doc_number] => 20200197325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => METHODS INVOLVING DOWNREGULATING APOBEC3B [patent_app_type] => utility [patent_app_number] => 16/531475 [patent_app_country] => US [patent_app_date] => 2019-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9374 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16531475 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/531475
METHODS INVOLVING DOWNREGULATING APOBEC3B Aug 4, 2019 Abandoned
Array ( [id] => 17035146 [patent_doc_number] => 20210252104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => ANTIBACTERIAL PEPTIDE MONOMERS AND COMBINATIONS FOR CO-THERAPY [patent_app_type] => utility [patent_app_number] => 17/259301 [patent_app_country] => US [patent_app_date] => 2019-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14393 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259301 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/259301
ANTIBACTERIAL PEPTIDE MONOMERS AND COMBINATIONS FOR CO-THERAPY Jul 11, 2019 Pending
Array ( [id] => 16383217 [patent_doc_number] => 10808039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-20 [patent_title] => Monomethylvaline compounds capable of conjugation to ligands [patent_app_type] => utility [patent_app_number] => 16/507839 [patent_app_country] => US [patent_app_date] => 2019-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 43 [patent_no_of_words] => 69869 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16507839 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/507839
Monomethylvaline compounds capable of conjugation to ligands Jul 9, 2019 Issued
Array ( [id] => 17913228 [patent_doc_number] => 20220315623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => Cyclic Peptide Compound Simulating Natural Product Structure, And Method For Preparation Thereof [patent_app_type] => utility [patent_app_number] => 17/610783 [patent_app_country] => US [patent_app_date] => 2019-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610783 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/610783
Cyclic Peptide Compound Simulating Natural Product Structure, And Method For Preparation Thereof Jun 20, 2019 Pending
Array ( [id] => 16954919 [patent_doc_number] => 11058747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-13 [patent_title] => Reconstituted high density lipoprotein formulation and production method thereof [patent_app_type] => utility [patent_app_number] => 16/445937 [patent_app_country] => US [patent_app_date] => 2019-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9781 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445937 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/445937
Reconstituted high density lipoprotein formulation and production method thereof Jun 18, 2019 Issued
Array ( [id] => 16992239 [patent_doc_number] => 20210230659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => Leader Sequence for Higher Expression of Recombinant Proteins [patent_app_type] => utility [patent_app_number] => 17/053596 [patent_app_country] => US [patent_app_date] => 2019-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8393 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17053596 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/053596
Leader Sequence for Higher Expression of Recombinant Proteins Jun 17, 2019 Pending
Array ( [id] => 17355404 [patent_doc_number] => 20220016200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS [patent_app_type] => utility [patent_app_number] => 17/312351 [patent_app_country] => US [patent_app_date] => 2019-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7026 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312351 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/312351
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS Jun 13, 2019 Pending
Array ( [id] => 17020919 [patent_doc_number] => 20210244790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => ENHANCEMENT OF ANTIBACTERIAL ACTIONS OF A DEPSIPEPTIDE ANTIBIOTIC USING SYNERGISTIC AMOUNTS OF BORIC ACID [patent_app_type] => utility [patent_app_number] => 17/251367 [patent_app_country] => US [patent_app_date] => 2019-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11855 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251367 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/251367
ENHANCEMENT OF ANTIBACTERIAL ACTIONS OF A DEPSIPEPTIDE ANTIBIOTIC USING SYNERGISTIC AMOUNTS OF BORIC ACID Jun 11, 2019 Pending
Array ( [id] => 16990264 [patent_doc_number] => 20210228684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => SILK-BASED PRODUCT FORMULATIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/972021 [patent_app_country] => US [patent_app_date] => 2019-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 132642 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972021 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/972021
Silk-based product formulations and methods of use Jun 3, 2019 Issued
Array ( [id] => 16913886 [patent_doc_number] => 20210186978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => COMBINATION THERAPY [patent_app_type] => utility [patent_app_number] => 15/734110 [patent_app_country] => US [patent_app_date] => 2019-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17569 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734110 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/734110
COMBINATION THERAPY May 30, 2019 Pending
Menu